1611441-30-5Relevant articles and documents
Discovery of dipeptidyl peptidase IV (DPP4) inhibitors based on a novel indole scaffold
Xiao, Peng-Fei,Guo, Rui,Huang, Shao-Qiang,Cui, Heng-Jun,Ye, Sheng,Zhang, Zhiyuan
, p. 673 - 676 (2014/06/09)
Dipeptidyl peptidase IV (DPP4) inhibitors are proven in the treatment of type 2 diabetes. We designed and synthesized a series of novel indole compounds that selectively inhibit the activity of DPP4 over dipeptidyl peptidase 9 (DPP9) (>200 fold). We further co-crystallized DPP4 with indole sulfonamide (compound 1) to confirm a proposed binding mode. Good metabolic stability of the indole compounds represents another positive attribute for further development.